ALEXANDRIA MELI: Open Payments
NPI 1447870027 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 27 payments from 7 companies in 2025. Trend: 2023 $144 · 2024 $82 · 2025 $982
Food & beverage: $769Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $436 |
| Otsuka America Pharmaceutical, Inc. | 9 | $243 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| Alkermes, Inc. | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $18 |
Products named: REXULTI, UZEDY, Auvelity, CAPLYTA, ARISTADA, AUSTEDO XR, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
